A circRNA signature was identified as a potential noninvasive biomarker for LUAD diagnosis. This study aimed to evaluate whether circulating circRNAs could be used as diagnostic biomarkers for lung adenocarcinoma (LUAD). READ ARTICLE
Journal of Translational Medicine
DOI:10.1186/s12967-019-1800-z
Authors: Xiao-Xia Liu, Yi-E Yang, Xiao Liu, Meng-Yu Zhang, Rui Li, Yun-Hong Yin, and Yi-Qing Qu